NPPA fixes retail price of 74 formulations - Video
|
Overview
Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizer, the Government of India has fixed the retail prices of the 74 scheduled formulations including those used to lower the levels of triglycerides in blood, to prevent heart attack and stroke, to treat high blood pressure, type 2 diabetes, and gastro-oesophageal reflux disease.
This came in line with the decision of the 109th authority meeting dated 21.02.2023, where the authority discussed the new drug applications for price fixation under para 5 and 15 of DPCO 2013.
For more details, check out the link given below:
Speakers
Payodhi Chaturvedi
Bachelor of Journalism and Mass Communication
Payodhi Chaturvedi joined Medical Dialogues in 2023. She has completed her Bachelor of Journalism and Mass Communication from IMS GHAZIABAD and currently pursuing Masters in journalism and Mass Communication from Gautam Budha University, Greater Noida. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751.
